InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Fry Hannah. Director active across 1 company, notably Protara Therapeutics, Inc.. Aggregated, 12 reports have been logged. History available since 16 July 2022. The latest transaction was disclosed on 26 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations
Fry Hannah is a declarant linked to Protara Therapeutics, Inc., where the listed role is VP, Controller. She has 12 filings in total, and within the recent sampled filings held, the date range runs from 2022-07-19 to 2026-01-27, with the dominant transaction nature listed as tax withholding.